{"transactions":[{"id":917251,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67547,"kind":"person","name":"Morales Mallory","position":1,"cik":"0001941795","reported_name":"Morales Mallory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Finance, CAO"}}],"security":"Stock Option","published_at":"2026-02-05T13:22:31.000Z","date":"2026-02-03","kind":"grant","planned":false,"acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2026, and will be fully vested and exercisable on January 1, 2030."}],"balance_after":140000,"derivative":{"exercise_price":4.91,"expiration_date":"2036-02-03","underlying":"Class A Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001790340-26-000026","document":"wk-form4_1770297748.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000179034026000026/wk-form4_1770297748.xml","form_type":"4"}},{"id":1026382,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67547,"kind":"person","name":"Morales Mallory","position":1,"cik":"0001941795","reported_name":"Morales Mallory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Class A Common Stock","published_at":"2025-10-02T13:02:58.000Z","date":"2025-10-01","kind":"purchase","planned":false,"acquired":true,"shares":300,"price":6.39,"value":1917.0,"ownership":{"direct":true},"balance_after":27533,"source":{"system":"sec-edgar","filing":"0001790340-25-000125","document":"wk-form4_1759410175.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000179034025000125/wk-form4_1759410175.xml","form_type":"4"}},{"id":1036962,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67547,"kind":"person","name":"Morales Mallory","position":1,"cik":"0001941795","reported_name":"Morales Mallory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Class A Common Stock","published_at":"2025-09-17T20:35:58.000Z","date":"2025-09-15","kind":"grant","planned":false,"acquired":true,"shares":14497,"price":1.428,"value":20701.716,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's Class A Common Stock pursuant to the Immuneering Corporation 2021 Employee Stock Purchase Plan (the\n\"ESPP\"), for the ESPP purchase period of March 16, 2025 through September 15, 2025. This transaction is also exempt pursuant to Rule 16b-3(c) promulgated pursuant to the Securities Exchange Act of\n1934."},{"field":"date","element":"transactionDate","label":"F2","text":"The relevant Offering Period (as defined in the ESPP) ended, and the shares were acquired, on the Purchase Date (as defined in the ESPP) of September 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In accordance with the ESPP, the shares were purchased at a price not less than eighty-five percent (85%) of the Fair Market Value (as defined in the ESPP) of a share of Class A Common Stock on\nthe Enrollment Date (as defined in the ESPP) of the relevant Offering Period."}],"balance_after":27233,"source":{"system":"sec-edgar","filing":"0001790340-25-000113","document":"wk-form4_1758141356.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000179034025000113/wk-form4_1758141356.xml","form_type":"4"}},{"id":1278282,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67547,"kind":"person","name":"Morales Mallory","position":1,"cik":"0001941795","reported_name":"Morales Mallory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option","published_at":"2025-02-07T21:25:17.000Z","date":"2025-02-05","kind":"grant","planned":false,"acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2025, and will be fully vested and exercisable on January 1, 2029."}],"balance_after":110000,"derivative":{"exercise_price":1.91,"expiration_date":"2035-02-05","underlying":"Class A Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001790340-25-000032","document":"wk-form4_1738963510.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000179034025000032/wk-form4_1738963510.xml","form_type":"4"}},{"id":1404421,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67547,"kind":"person","name":"Morales Mallory","position":1,"cik":"0001941795","reported_name":"Morales Mallory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Class A Common Stock","published_at":"2024-09-17T20:09:02.000Z","date":"2024-09-15","kind":"grant","planned":false,"acquired":true,"shares":4458,"price":1.6235,"value":7237.563,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's Class A Common Stock pursuant to the Immuneering Corporation 2021 Employee Stock Purchase Plan (the \"ESPP\"), for the ESPP purchase period of March 15, 2024 through September 15, 2024. This transaction is also exempt pursuant to Rule 16b-3(c) promulgated pursuant to the Securities Exchange Act of 1934."},{"field":"date","element":"transactionDate","label":"F2","text":"The relevant Offering Period (as defined in the ESPP) ended, and the shares were acquired, on the Purchase Date (as defined in the ESPP) of September 15, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In accordance with the ESPP, the shares were purchased at a price not less than eighty-five percent (85%) of the Fair Market Value (as defined in the ESPP) of a share of Class A Common Stock on the Enrollment Date (as defined in the ESPP) of March 15, 2024."}],"balance_after":12736,"source":{"system":"sec-edgar","filing":"0001790340-24-000071","document":"wk-form4_1726603736.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000179034024000071/wk-form4_1726603736.xml","form_type":"4"}},{"id":1503149,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67547,"kind":"person","name":"Morales Mallory","position":1,"cik":"0001941795","reported_name":"Morales Mallory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option","published_at":"2024-05-23T20:18:10.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":72000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2023, and will be fully vested and exercisable on January 1, 2027."}],"balance_after":72000,"derivative":{"exercise_price":3.01,"expiration_date":"2033-02-15","underlying":"Class A Common Stock","underlying_shares":72000},"source":{"system":"sec-edgar","filing":"0001628280-24-024950","document":"wk-form4_1716495475.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000162828024024950/wk-form4_1716495475.xml","form_type":"4"}},{"id":1503148,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67547,"kind":"person","name":"Morales Mallory","position":1,"cik":"0001941795","reported_name":"Morales Mallory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option","published_at":"2024-05-23T20:18:10.000Z","date":"2024-05-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":72000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2023, and will be fully vested and exercisable on January 1, 2027."}],"balance_after":0,"derivative":{"exercise_price":4.25,"expiration_date":"2033-02-15","underlying":"Class A Common Stock","underlying_shares":72000},"source":{"system":"sec-edgar","filing":"0001628280-24-024950","document":"wk-form4_1716495475.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000162828024024950/wk-form4_1716495475.xml","form_type":"4"}},{"id":1503147,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67547,"kind":"person","name":"Morales Mallory","position":1,"cik":"0001941795","reported_name":"Morales Mallory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option","published_at":"2024-05-23T20:18:10.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":60500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2024, and will be fully vested and exercisable on January 1, 2028."}],"balance_after":60500,"derivative":{"exercise_price":3.01,"expiration_date":"2034-02-08","underlying":"Class A Common Stock","underlying_shares":60500},"source":{"system":"sec-edgar","filing":"0001628280-24-024950","document":"wk-form4_1716495475.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000162828024024950/wk-form4_1716495475.xml","form_type":"4"}},{"id":1503146,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67547,"kind":"person","name":"Morales Mallory","position":1,"cik":"0001941795","reported_name":"Morales Mallory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option","published_at":"2024-05-23T20:18:10.000Z","date":"2024-05-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":60500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2024, and will be fully vested and exercisable on January 1, 2028."}],"balance_after":0,"derivative":{"exercise_price":6.09,"expiration_date":"2034-02-08","underlying":"Class A Common Stock","underlying_shares":60500},"source":{"system":"sec-edgar","filing":"0001628280-24-024950","document":"wk-form4_1716495475.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000162828024024950/wk-form4_1716495475.xml","form_type":"4"}},{"id":1503145,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67547,"kind":"person","name":"Morales Mallory","position":1,"cik":"0001941795","reported_name":"Morales Mallory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option","published_at":"2024-05-23T20:18:10.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests and becomes exercisable (subject to continued service to the Issuer through the applicable vesting date) in forty-eight (48) equal monthly installments following the vesting commencement date of July 1, 2023, and will be fully vested and exercisable on July 1, 2027."}],"balance_after":15000,"derivative":{"exercise_price":3.01,"expiration_date":"2033-06-13","underlying":"Class A Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001628280-24-024950","document":"wk-form4_1716495475.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000162828024024950/wk-form4_1716495475.xml","form_type":"4"}},{"id":1503144,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67547,"kind":"person","name":"Morales Mallory","position":1,"cik":"0001941795","reported_name":"Morales Mallory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option","published_at":"2024-05-23T20:18:10.000Z","date":"2024-05-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests and becomes exercisable (subject to continued service to the Issuer through the applicable vesting date) in forty-eight (48) equal monthly installments following the vesting commencement date of July 1, 2023, and will be fully vested and exercisable on July 1, 2027."}],"balance_after":0,"derivative":{"exercise_price":9.55,"expiration_date":"2033-06-13","underlying":"Class A Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001628280-24-024950","document":"wk-form4_1716495475.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000162828024024950/wk-form4_1716495475.xml","form_type":"4"}},{"id":1503143,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67547,"kind":"person","name":"Morales Mallory","position":1,"cik":"0001941795","reported_name":"Morales Mallory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option","published_at":"2024-05-23T20:18:10.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on July 31, 2022, and will be fully vested and exercisable on June 30, 2026."}],"balance_after":5000,"derivative":{"exercise_price":3.01,"expiration_date":"2032-06-30","underlying":"Class A Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001628280-24-024950","document":"wk-form4_1716495475.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000162828024024950/wk-form4_1716495475.xml","form_type":"4"}},{"id":1503142,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67547,"kind":"person","name":"Morales Mallory","position":1,"cik":"0001941795","reported_name":"Morales Mallory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option","published_at":"2024-05-23T20:18:10.000Z","date":"2024-05-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on July 31, 2022, and will be fully vested and exercisable on June 30, 2026."}],"balance_after":0,"derivative":{"exercise_price":5.41,"expiration_date":"2032-06-30","underlying":"Class A Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001628280-24-024950","document":"wk-form4_1716495475.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000162828024024950/wk-form4_1716495475.xml","form_type":"4"}},{"id":1503141,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67547,"kind":"person","name":"Morales Mallory","position":1,"cik":"0001941795","reported_name":"Morales Mallory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option","published_at":"2024-05-23T20:18:10.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":23850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2022, and will be fully vested and exercisable on January 1, 2026."}],"balance_after":23850,"derivative":{"exercise_price":3.01,"expiration_date":"2032-02-10","underlying":"Class A Common Stock","underlying_shares":23850},"source":{"system":"sec-edgar","filing":"0001628280-24-024950","document":"wk-form4_1716495475.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000162828024024950/wk-form4_1716495475.xml","form_type":"4"}},{"id":1503140,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67547,"kind":"person","name":"Morales Mallory","position":1,"cik":"0001941795","reported_name":"Morales Mallory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option","published_at":"2024-05-23T20:18:10.000Z","date":"2024-05-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":23850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2022, and will be fully vested and exercisable on January 1, 2026."}],"balance_after":0,"derivative":{"exercise_price":9.66,"expiration_date":"2032-02-10","underlying":"Class A Common Stock","underlying_shares":23850},"source":{"system":"sec-edgar","filing":"0001628280-24-024950","document":"wk-form4_1716495475.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000162828024024950/wk-form4_1716495475.xml","form_type":"4"}},{"id":1503139,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67547,"kind":"person","name":"Morales Mallory","position":1,"cik":"0001941795","reported_name":"Morales Mallory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option","published_at":"2024-05-23T20:18:10.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested."}],"balance_after":10000,"derivative":{"exercise_price":3.01,"expiration_date":"2032-08-11","underlying":"Class A Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001628280-24-024950","document":"wk-form4_1716495475.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000162828024024950/wk-form4_1716495475.xml","form_type":"4"}},{"id":1503138,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67547,"kind":"person","name":"Morales Mallory","position":1,"cik":"0001941795","reported_name":"Morales Mallory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option","published_at":"2024-05-23T20:18:10.000Z","date":"2024-05-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 21, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced to an exercise price of $3.01 per share. Under the terms of the Repricing, unless there is a change of control of the Issuer, the exercise price for the repriced options will revert to the original exercise price of the option if, prior to June 30, 2025, the Reporting Person: (i) is terminated by the Issuer for cause or resigns from the Issuer, except by reason of death or disability; or (ii) elects to exercise the repriced options. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":6.33,"expiration_date":"2032-08-11","underlying":"Class A Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001628280-24-024950","document":"wk-form4_1716495475.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000162828024024950/wk-form4_1716495475.xml","form_type":"4"}},{"id":1561612,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67547,"kind":"person","name":"Morales Mallory","position":1,"cik":"0001941795","reported_name":"Morales Mallory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Class A Common Stock","published_at":"2024-03-25T13:04:48.000Z","date":"2024-03-22","kind":"purchase","planned":false,"acquired":true,"shares":393,"price":2.5455,"value":1000.3815,"ownership":{"direct":true},"balance_after":8278,"source":{"system":"sec-edgar","filing":"0001790340-24-000038","document":"wk-form4_1711371878.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000179034024000038/wk-form4_1711371878.xml","form_type":"4"}},{"id":1561611,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67547,"kind":"person","name":"Morales Mallory","position":1,"cik":"0001941795","reported_name":"Morales Mallory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Class A Common Stock","published_at":"2024-03-25T13:04:48.000Z","date":"2024-03-21","kind":"purchase","planned":false,"acquired":true,"shares":1107,"price":2.7179,"value":3008.7153,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $2.675 to $2.74. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares acquired at each price."}],"balance_after":7885,"source":{"system":"sec-edgar","filing":"0001790340-24-000038","document":"wk-form4_1711371878.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000179034024000038/wk-form4_1711371878.xml","form_type":"4"}},{"id":1561610,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67547,"kind":"person","name":"Morales Mallory","position":1,"cik":"0001941795","reported_name":"Morales Mallory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Class A Common Stock","published_at":"2024-03-25T13:04:48.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":4344,"price":1.62,"value":7037.28,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's Class A Common Stock pursuant to the Immuneering Corporation 2021 Employee Stock Purchase Plan (the \"ESPP\"), for the ESPP purchase period of September 15, 2023 through March 15, 2024. This transaction is also exempt pursuant to Rule 16b-3(c) promulgated pursuant to the Securities Exchange Act of 1934."},{"field":"date","element":"transactionDate","label":"F2","text":"The relevant Offering Period (as defined in the ESPP) ended, and the shares were acquired, on the Purchase Date (as defined in the ESPP) of March 15, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In accordance with the ESPP, the shares were purchased at a price not less than eighty-five percent (85%) of the Fair Market Value (as defined in the ESPP) of a share of Class A Common Stock on the Purchase Date of March 15, 2024."}],"balance_after":6778,"source":{"system":"sec-edgar","filing":"0001790340-24-000038","document":"wk-form4_1711371878.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000179034024000038/wk-form4_1711371878.xml","form_type":"4"}},{"id":1651148,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67547,"kind":"person","name":"Morales Mallory","position":1,"cik":"0001941795","reported_name":"Morales Mallory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option","published_at":"2024-02-09T21:30:24.000Z","date":"2024-02-08","kind":"grant","planned":false,"acquired":true,"shares":60500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2024, and will be fully vested and exercisable on January 1, 2028."}],"balance_after":60500,"derivative":{"exercise_price":6.09,"expiration_date":"2034-02-08","underlying":"Class A Common Stock","underlying_shares":60500},"source":{"system":"sec-edgar","filing":"0001790340-24-000016","document":"wk-form4_1707514195.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000179034024000016/wk-form4_1707514195.xml","form_type":"4"}},{"id":1855420,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67547,"kind":"person","name":"Morales Mallory","position":1,"cik":"0001941795","reported_name":"Morales Mallory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VICE PRESIDENT, FINANCE"}}],"security":"Stock Option","published_at":"2023-06-14T20:15:00.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable (subject to continued service to the Issuer through the applicable vesting date) in forty-eight (48) substantially equal monthly installments following the vesting commencement date of July 1, 2023, and will be fully vested and exercisable on July 1, 2027."}],"balance_after":15000,"derivative":{"exercise_price":9.55,"expiration_date":"2033-06-13","underlying":"Class A Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001790340-23-000027","document":"wk-form4_1686773684.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000179034023000027/wk-form4_1686773684.xml","form_type":"4"}},{"id":2006291,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67547,"kind":"person","name":"Morales Mallory","position":1,"cik":"0001941795","reported_name":"Morales Mallory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VICE PRESIDENT, FINANCE"}}],"security":"Stock Option","published_at":"2023-02-17T21:30:36.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":72000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2023, and will be fully vested and exercisable on January 1, 2027."}],"balance_after":72000,"derivative":{"exercise_price":4.25,"expiration_date":"2033-02-15","underlying":"Class A Common Stock","underlying_shares":72000},"source":{"system":"sec-edgar","filing":"0001415889-23-002773","document":"form4-02172023_090206.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000141588923002773/form4-02172023_090206.xml","form_type":"4"}},{"id":2186494,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":67547,"kind":"person","name":"Morales Mallory","position":1,"cik":"0001941795","reported_name":"Morales Mallory","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VICE PRESIDENT, FINANCE"}}],"security":"Stock Option","published_at":"2022-08-12T20:15:35.000Z","date":"2022-08-11","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the option vests and becomes exercisable on August 11, 2023, subject Ms. Morales' continued employment through such date."}],"balance_after":10000,"derivative":{"exercise_price":6.33,"expiration_date":"2032-08-11","underlying":"Class A Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-22-008536","document":"form4-08122022_040801.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790340/000141588922008536/form4-08122022_040801.xml","form_type":"4"}}]}